STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
HCAT HEALTH CATALYST INCORPORATED StockScouter® Report
6
StockScouter® Score
HEALTH CATALYST INCORPORATED, a small cap value company in the technology sector, is expected to slightly underperform the market over the next six months with average risk
10 is the best possible rating. Learn more.
Summary
Positives
- Earnings growth in the past year has accelerated moderately compared to earnings growth in the past three years. Positive
- The enterprise value-to-sales ratio is approximately in line with that of comparably-sized companies in the StockScouter universe. Neutral
Concerns
- The multi-period measure of relative price change and consistency is well below average. Negative
- Moving average analysis for HCAT suggests weak price movement over the medium term. Negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that small cap stocks will be in favor, value stocks will be neutral, and technology stocks will be in favor.
Expected Risk/Return
Core Model Grades
C
C
C
F